Sudhir Sahasrabudhe
Direktor/Vorstandsmitglied bei Utah State University Foundation
Aktive Positionen von Sudhir Sahasrabudhe
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Utah State University Foundation | Direktor/Vorstandsmitglied | - | - |
Massachusetts Institute of Technology | Corporate Officer/Principal | - | - |
Karriereverlauf von Sudhir Sahasrabudhe
Ehemalige bekannte Positionen von Sudhir Sahasrabudhe
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MYRIAD GENETICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Vorstandsvorsitzender | 01.01.2001 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 | - |
Ausbildung von Sudhir Sahasrabudhe
University of Baroda | Graduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Indien | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Chief Executive Officer | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MYRIAD GENETICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Health Technology |
Utah State University Foundation | |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
- Börse
- Insiders
- Sudhir Sahasrabudhe
- Erfahrung